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background:  Although there has been a recent push towards high-dose statin therapy use in cardiovascular disease (CVD) patients, it is unknown 
whether high-dose statins (HDS) are associated with a lower adherence compared to low-moderate dose statins (LMDS).
methods:  In a national database of 972532 CVD (ischemic heart disease, peripheral artery disease, ischemic stroke) patients from 130 Veterans 
Health Administration facilities, we identified patients receiving HDS (>40 mg atorvastatin, >20 mg rosuvastatin, 80 mg simvastatin) between 
October 1, 2010 to September 30, 2011. We assessed statin adherence by calculating proportion of days covered (PDC) defined as the total number 
of days supplied for each statin fill divided by the observation interval (365 days). We performed multivariate regression to identify whether HDS use 
was independently associated with a lower PDC.
results:  Statins were prescribed in 629,005 (64.7%) patients. Of those, 229,437 (36.5%) received HDS. Mean PDC (0.87 vs. 0.86, p <.001) and 
proportion of patients with PDC >0.8 (76.3% vs. 74.2%, p <.001) were slightly higher for LMDS compared to HDS. In adjusted analyses (Table), HDS 
use was associated with a significant but modest reduction in adherence compared with LMDS use whether continuous PDC or PDC >0.8 was used 
as statin adherence measure.
conclusions:  Our results suggest that an approach of HDS treatment in CVD patients will lead to a very modest reduction in adherence compared 
to LMDS.
